This study will compare the efficacy, safety and durability of two different strategies to treat participants with a history of sub-optimal adherence and control of their HIV infection: long-acting (LA) antiretroviral therapy with rilpivirine (RPV) LA and cabotegravir (CAB) LA versus all-oral standard of care (SOC). More details can be found here.
